80536 Federal Register / Vol. 75, No. 245 / Wednesday, December 22, 2010 / Notices 

DEPARTMENT OF JUSTICE 

Antitrust Division 

Notice Pursuant to the National 

Cooperative Research and Production 

Act of 1993 Vehicle Infrastructure 

Integration Consortium 

Notice is hereby given that, on 

November 24, 2010, pursuant to Section 

6(a) of the National Cooperative 

Research and Production Act of 1993, 

15 U.S.C. 4301 et seq. (‘‘the Act’’), the 

Vehicle Infrastructure Integration 

Consortium (‘‘VIIC’’) has filed written 

notifications simultaneously with the 

Attorney General and the Federal Trade 

Commission disclosing changes in its 

membership. The notifications were 

filed for the purpose of extending the 

Act’s provisions limiting the recovery of 

antitrust plaintiffs to actual damages 

under specified circumstances. 

Specifically, Nissan North America, 

Inc., Franklin Hills, TN, has succeeded 

Nissan North America Technical Center, 

Inc., Farmington Hills, MI, as a member, 

and the name of the member previously 

listed as Mercedes-Benz Research & 

Technology North America, Inc. is 

corrected to read Mercedes-Benz 

Research & Development North 

America, Inc., Palo Alto, CA. 

No other changes have been made in 

either the membership or planned 

activity of the group research project. 

Membership in this group research 

project remains open, and VIIC intends 

to file additional written notification 

disclosing all changes in membership. 

On May 1, 2006, VIIC filed its original 

notification pursuant to Section 6(a) of 

the Act. The Department of Justice 

published a notice in the Federal 

Register pursuant to Section 6(b) of the 

Act on June 2, 2006 (71 FR 32128). 

The last notification was filed with 

the Department on March 11, 2008. A 

notice was published in the Federal 

Register pursuant to Section 6(b) of the 

Act on April 7, 2008 (71 FR 18811). 

Patricia A. Brink, 

Director of Civil Enforcement, Antitrust 

Division. 

[FR Doc. 2010–32053 Filed 12–21–10; 8:45 am] 

BILLING CODE 4410–11–M 

DEPARTMENT OF JUSTICE 

Antitrust Division 

Notice Pursuant to the National 

Cooperative Research and Production 

Act of 1993 National Warheads and 

Energetics Consortium 

Notice is hereby given that, on 

November 30, 2010, pursuant to Section 

6(a) of the National Cooperative 

Research and Production Act of 1993, 

15 U.S.C. 4301 et seq. (‘‘the Act’’), 

National Warheads and Energetics 

Consortium (‘‘NWEC’’) has filed written 

notifications simultaneously with the 

Attorney General and the Federal Trade 

Commission disclosing changes in its 

membership. The notifications were 

filed for the purpose of extending the 

Act’s provisions limiting the recovery of 

antitrust plaintiffs to actual damages 

under specified circumstances. 

Specifically, Franklin Engineering 

Group, Inc., Franklin, TN; RDM 

Engineering, LLC, East Brunswick, NJ; 

Rocky Mountain Scientific Laboratory, 

Centennial, CO; Rocky Research, 

Boulder City, NV; The Research 

Foundation of State University of New 

York, Binghamton, NY; and Wilkes 

University, Wilkes-Barre, PA, have been 

added as parties to this venture. 

Also, AMTEC Corporation, Janesville, 

WI; Atlantic Technical Components, 

Inc., Middletown, NY; CAE Solutions 

Corp., Fremont, CA; and Clear Align, 

Eagleville, PA, have withdrawn as 

parties to this venture. No other changes 

have been made in either the 

membership or planned activity of the 

group research project. Membership in 

this group research project remains 

open, and NWEC intends to file 

additional written notifications 

disclosing all changes in membership. 

On May 2, 2000, NWSC filed its 

original notification pursuant to Section 

6(a) oi the Act. The Department of 

Justice published a notice in the Federal 

Register pursuant to Section 6(b) of the 

Act on June 30, 2010 (65 PR 40963). 

The last notification was filed with 

the Department on August 16, 2010. A 

norice was published in the Federal 

Register pursuant to Section 6(b) of the 

Act on September 8, 2010 (74 FR 

54652). 

Patricia A. Brink, 

Director of Civil Enforcement, Antitrust 

Division. 

[FR Doc. 2010–32052 Filed 12–21–10; 8:45 am] 

BILLING CODE 4410–11–M 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–316N] 

RIN 1117–AB18 

Procedures for the Surrender of 

Unwanted Controlled Substances by 

Ultimate Users; Notice of Meeting 

AGENCY: Drug Enforcement 

Administration, Department of Justice. 

ACTION: Notice of meeting. 

SUMMARY: The Drug Enforcement 

Administration (DEA) is conducting a 

public meeting to discuss procedures for 

the surrender of unwanted controlled 

substances by ultimate users and long 

term care facilities in the development 

of regulations to implement the Secure 

and Responsible Drug Disposal Act of 

2010. Specifically, DEA invites all 

interested persons, including ultimate 

users, pharmacies, law enforcement, 

reverse distributors, and other third 

parties to express their views at the 

meeting or by written comment 

concerning the most safe and effective 

method of disposal of controlled 

substances consistent with the 

Controlled Substances Act and the 

Secure and Responsible Drug Disposal 

Act of 2010. 

DATES: This meeting will be held 

Wednesday, January 19, 2011, and 

Thursday, January 20, 2011, 9 a.m. until 

5:30 p.m. Check-in will begin at 8 a.m. 

This meeting will be held at the 

Mayflower Renaissance Washington, DC 

Hotel, 1127 Connecticut Avenue, NW., 

Washington, DC 20036; (202) 347–3000. 

MEETING ATTENDANCE: Persons wishing 

to attend this meeting, space permitting, 

must provide attendee information to 

the Liaison and Policy Section, Office of 

Diversion Control, Drug Enforcement 

Administration, via e-mail: 

dea.diversion.policy@usdoj.gov. DEA 

will only accept requests to attend this 

public meeting by e-mail. Please include 

‘‘Disposal meeting attendee information’’ 

in the subject line of the e-mail. Persons 

wishing to attend this meeting must 

provide the information requested 

under ‘‘Meeting Participation’’ to the 

Liaison and Policy Section via e-mail no 

later than January 12, 2011. There is no 

fee to register for the meeting and 

registrations will be accepted on a firstcome, first-served basis. Early 

registration is encouraged because 

seating is limited. 

MEETING PRESENTATIONS: DEA is 

accepting requests to make limited oral 

presentations during the public meeting, 

as discussed further in this document. 

Persons wishing to give an oral 

presentation at this meeting, space and 

time permitting, must provide attendee 

information and indicate the desire to 

present at this public meeting to the 

Liaison and Policy Section, Office of 

Diversion Control, Drug Enforcement 

Administration, via e-mail to 

dea.diversion.policy@usdoj.gov. DEA 

will only accept requests to present at 

this public meeting by e-mail. Please 

include ‘‘Disposal meeting: Request to 

present’’ in the subject line of the e-mail. 


srobinson on DSKHWCL6B1PROD with NOTICES
Federal Register / Vol. 75, No. 245 / Wednesday, December 22, 2010 / Notices 80537 

1Office of National Drug Control Policy 2008 

‘‘Prescription for Danger’’ January 24, 2008 

2 2009 National Survey on Drug Use and Health 

(NSDUH), September 2010. 

Persons wishing to give an oral 

presentation at this meeting must 

provide the information requested 

under ‘‘Meeting Participation’’ to the 

Liaison and Policy Section no later than 

January 7, 2011. Persons and groups 

having similar interests may wish to 

consider consolidating their information 

for an oral presentation through a single 

representative. After reviewing the 

requests to present, DEA will respond to 

all persons that request an oral 

presentation to notify them of the status 

of their request. If selected to give an 

oral presentation, DEA will notify the 

presenting person or party of the 

amount of time available to present and 

the approximate time the participant’s 

presentation is scheduled to begin. 

SUBMISSION OF WRITTEN COMMENTS: DEA 

is accepting written comments as 

discussed further in this document. 

Commenters should reference ‘‘Docket 

No. DEA–316’’ on all electronic and 

written correspondence. Written 

comments must be postmarked and 

electronic comments must be submitted 

on or before January 12, 2011. 

Commenters should be aware that the 

electronic Federal Docket Management 

System will not accept comments after 

midnight Eastern Time on the last day 

of the comment period. 

Comments may be sent electronically 

through http://www.regulations.gov 

using the electronic comment form 

provided on that site. Please note that 

DEA is requesting that electronic 

comments be submitted before midnight 

Eastern time on the day the comment 

period closes because http:// 

www.regulations.gov terminates the 

public’s ability to submit comments at 

midnight Eastern time on the day the 

comment period closes. Commenters in 

time zones other than Eastern time may 

want to consider this so that their 

electronic comments are received. 

Written comments sent via regular or 

express mail should be sent to the Drug 

Enforcement Administration, Attention: 

DEA Federal Register Representative/ 

ODL, 8701 Morrissette Drive, 

Springfield, VA 22152. All comments 

sent via regular or express mail will be 

considered timely if postmarked on the 

day the comment period closes. 

FOR FURTHER INFORMATION CONTACT: 

Mark W. Caverly, Chief, Liaison and 

Policy Section, Office of Diversion 

Control, Drug Enforcement 

Administration, 8701 Morrissette Drive, 

Springfield, VA 22152, telephone: (202) 

307–7297. 

SUPPLEMENTARY INFORMATION: 

Posting of Public Comments: All 

submitted comments will be made 

available to be viewed on the Web site: 

http://www.regulations.gov prior to the 

public meeting. A link to this electronic 

docket will be available at the DEA 

Diversion Control Program Web site, 

http://www.deadiversion.usdoj.gov. 

Please note that all comments 

received are considered part of the 

public record and made available for 

public inspection online at http:// 

www.regulations.gov and in the Drug 

Enforcement Administration’s public 

docket. Such information includes 

personal identifying information (such 

as your name, address, etc.) voluntarily 

submitted by the commenter. 

If you want to submit personal 

identifying information (such as your 

name, address, etc.) as part of your 

comment, but do not want it to be 

posted online or made available in the 

public docket, you must include the 

phrase ‘‘Personal Identifying 

Information’’ in the first paragraph of 

your comment. You must also place all 

the personal identifying information 

you do not want posted online or made 

available in the public docket in the first 

paragraph of your comment and identify 

what information you want redacted. 

If you want to submit confidential 

business information as part of your 

comment, but do not want it to be 

posted online or made available in the 

public docket, you must include the 

phrase ‘‘Confidential Business 

Informationm’’ in the first paragraph of 

your comment. You must also 

prominently identify confidential 

business information to be redacted 

within the comment. If a comment has 

so much confidential business 

information that it cannot be effectively 

redacted, all or part of that comment 

may not be posted online or made 

available in the public docket. 

Personal identifying information and 

confidential business information 

identified and located as set forth above 

will be redacted and the comment, in 

redacted form, will be posted online and 

placed in the Drug Enforcement 

Administration’s public docket file. 

Please note that the Freedom of 

Information Act applies to all comments 

received. If you wish to inspect the 

agency’s public docket file in person by 

appointment, please see the FOR

FURTHER INFORMATION CONTACT

paragraph. 

Background 

The nonmedical use of prescription 

drugs is a growing problem in the 

United States, particularly among 

teenagers. According to the Department 

of Justice’s 2009 National Prescription 

Drug Threat Assessment, unintentional 

overdose deaths involving prescription 

opioids increased 114 percent from 

2001 to 2005, and the number of 

treatment admissions for prescription 

opioids increased 74 percent from 2002 

to 2006. Teens abuse prescription drugs 

more than any illicit drug except 

marijuana—more than cocaine, heroin, 

and methamphetamine combined.1 In 

2009, 2.2 million (nearly one third 

(28.6%) of first time drug abusers) 

persons age 12 or older abused 

prescription drugs.2

DEA recognizes that abuse of 

prescription controlled substances is a 

significant issue in our nation’s 

communities. When originally enacted 

in 1970, the Controlled Substances Act 

(CSA) and its implementing regulations 

did not contemplate a situation in 

which an ultimate user would deliver 

previously dispensed controlled 

substances to another person or entity. 

The CSA defines an ultimate user of a 

controlled substance as ‘‘a person who 

has lawfully obtained, and who 

possesses, a controlled substance for his 

own use or for the use of a member of 

his household or for an animal owned 

by him or a member of his household’’ 

(21 U.S.C. 802(27)). Under the CSA, ‘‘the 

term ‘distribute’ means to deliver (other 

than by administering or dispensing) a 

controlled substance or a listed 

chemical.’’ (21 U.S.C. 802(11)). ‘‘The 

terms ‘deliver’ or ‘delivery’ mean the 

actual, constructive, or attempted 

transfer of a controlled substance or a 

listed chemical, whether or not there 

exists an agency relationship.’’ (21 

U.S.C. 802(8)). 

On October 12, 2010, the Secure and 

Responsible Drug Disposal Act of 2010 

(Pub. L. 111–273) was enacted. This act 

amended the Controlled Substances Act 

to allow ultimate users to dispose of 

unwanted controlled substances by 

delivering them to entities authorized 

by the Attorney General to accept them. 

This act also allows the Attorney 

General to authorize long term care 

facilities to dispose of their residents’ 

controlled substances in certain 

instances. DEA is currently drafting 

regulations that would allow for the 

disposal of unwanted controlled 

substances by those not registered with 

DEA. 

DEA has been charged by Congress 

with preventing diversion of controlled 

substances during the disposal process, 

and with considering the public health 

and safety as well as the ease and cost 

of program implementation and 

participation by various communities in 

drafting regulations to implement the 


srobinson on DSKHWCL6B1PROD with NOTICES
80538 Federal Register / Vol. 75, No. 245 / Wednesday, December 22, 2010 / Notices 

law. DEA also recognizes concerns 

raised by State and local governments, 

the healthcare industry, the law 

enforcement community, public and 

private environmental organizations, 

and individual citizens. In response to 

these concerns, DEA is holding a public 

meeting to gather information from 

interested persons regarding potential 

solutions within the framework of the 

Controlled Substances Act. 

As discussed above, DEA is seeking 

input in the form of oral presentations 

and written comments. Regardless of the 

format, specific concerns which persons 

are encouraged to address are as 

follows: 

• The process of the disposal of 

unwanted controlled substances could 

create new and unwanted avenues for 

diversion. What is the safest manner, in 

your opinion, to dispose of unwanted 

controlled substances while preventing 

diversion? 

• Please explain why you believe the 

solution you propose would protect the 

public health and safety and would 

curtail diversion. 

• Do you foresee any specific 

obstacles to the disposal of controlled 

substances in your community or 

geographical area? If so, what are they? 

• How is the disposal of controlled 

substances affected by State and local 

laws and regulations? 

Meeting Participation 

This meeting is open to the public. 

Persons and organizations representing 

state and local governments; law 

enforcement agencies; publicly owned 

treatment works; DEA-registered 

pharmacies; DEA-registered 

manufacturers, distributors, and reverse 

distributors; ultimate users of controlled 

substances (i.e., patients and members 

of their households); long term care 

facilities; hospices and in-home care 

groups; and other concerned 

organizations may be particularly 

interested in this meeting. 

Persons wishing to attend, or provide 

oral presentations at this meeting, time 

and space permitting, must provide the 

following information to the Liaison and 

Policy Section using the contact 

information listed above no later than 

January 7, 2011 (request to present) and 

January 12, 2011 (request to attend): 

Name: 

lllllllllllllllllll

Title: 

lllllllllllllllllll

Company/Organization: 

lllllllllllllllllll

Address: 

lllllllllllllllllll

Telephone: 

lllllllllllllllllll

E-mail address: 

lllllllllllllllllll

Date(s) you wish to attend: 

lllllllllllllllllll

Persons should clearly indicate in the 

subject line of their e-mail whether they 

are requesting to attend the meeting or 

requesting to present at the meeting, 

following the ‘‘Meeting Attendance’’ and 

‘‘Meeting Presentations’’ sections of this 

notice. 

Please note that this public meeting 

will not be webcast. A copy of the 

transcript from this public meeting will 

be made available at the DEA Diversion 

Control Program Web site, http:// 

www.deadiversion.usdoj.gov. 

Persons needing accommodations 

(e.g., sign language interpreter) are 

requested to notify DEA with their 

accommodation request no later than 

January 7, 2011. 

As this meeting is open to the public, 

confidential business information or 

other proprietary information should 

NOT be shared. 

Persons wishing to provide written 

comments may do so no later than 

January 12, 2011. All comments will be 

made available at http:// 

www.regulations.gov in the electronic 

docket for this notice of meeting. A link 

to the electronic docket may be found at 

http://www.deadiversion.usdoj.gov. 

Please see the ‘‘Submission of Written 

Comments’’ section for further 

information regarding providing written 

comments. 

Dated: December 16, 2010. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control. 

[FR Doc. 2010–32104 Filed 12–21–10; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF LABOR 

Office of the Secretary 

Agency Information Collection 

Activities; Submission for OMB 

Review; Comment Request; Safety 

Defects; Examination, Correction, and 

Records 

ACTION: Notice. 

SUMMARY: The Department of Labor 

(DOL) hereby announces the submission 

of the Mine Safety and Health 

Administration (MSHA)sponsored 

information collection request (ICR) 

titled, ‘‘Safety Defects; Examination, 

Correction, and Records,’’ to the Office 

of Management and Budget (OMB) for 

review and approval for continued use 

in accordance with the Paperwork 

Reduction Act of 1995 (Pub. L. 104–13, 

44 U.S.C. chapter 35). 

DATES: Submit comments on or before 

January 21, 2011. 

ADDRESSES: A copy of this ICR, with 

applicable supporting documentation; 

including a description of the likely 

respondents, proposed frequency of 

response, and estimated total burden 

may be obtained from the RegInfo.gov 

Web site, http://www.reginfo.gov/ 

public/do/PRAMain or by contacting 

Michel Smyth by telephone at 202–693– 

4129 (this is not a toll-free number) or 

sending an e-mail to 

DOL_PRA_PUBLIC@dol.gov. 

Submit comments about this request 

to the Office of Information and 

Regulatory Affairs, Attn: OMB Desk 

Officer for the Department of Labor, 

Mine Safety and Health Administration 

(MSHA), Office of Management and 

Budget, Room 10235, Washington, DC 

20503, Telephone: 202–395–4816/Fax: 

202–395–6881 (these are not toll-free 

numbers), e-mail: 

OIRA_submission@omb.eop.gov. 

FOR FURTHER INFORMATION CONTACT: 

Michel Smyth by telephone at 202–693– 

4129 (this is not a toll-free number) or 

by e-mail at 

DOL_PRA_PUBLIC@dol.gov. 

SUPPLEMENTARY INFORMATION: Federal 

Mine Safety and Health Act of 1977 

(Mine Act) section 103(h), 30 U.S.C. 

813(h), authorizes the MSHA to collect 

information necessary to carry out its 

duty in protecting the safety and health 

of miners. 

Regulations 30 CFR 56.13015 and 

57.13015 require compressed-air 

receivers and other unfired pressure 

vessels to be inspected by inspectors 

holding a valid National Board 

Commission and in accordance with the 

applicable chapters of the National 

Board Inspection Code, a Manual for 

Boiler and Pressure Vessels Inspectors, 

1979. Safety defects found on 

compressed-air receivers and other 

unfired pressure vessels have caused 

injuries and fatalities in the mining 

industry. Records of inspections must 

be kept in accordance with the 

requirements of the National Board 

Inspection Code and the records must 

be made available to the Secretary or an 

authorized representative. 

Regulations 30 CFR 56.13030 and 

57.13030 require that fired pressure 

vessels (boilers) must be equipped with 

water level gauges, pressure gauges, 

automatic pressure-relief valves, 

blowdown piping and other safety 

devices approved by the American 

Society of Mechanical Engineers 

(ASME) to protect against hazards from 


srobinson on DSKHWCL6B1PROD with NOTICES